PROCESSED AT :

Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY (5600162028),SWATHI,M1, 2ND MAIN, URBAN
: DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : URINARY MICROALBUMIN Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME TECHNOLOGY VALUE UNITS

DIABETES SCREEN (URINE)
URINARY MICROALBUMIN PHOTOMETRY 18.2 µg/mL
Bio. Ref. Interval. :
Adults: Less than 25 µg/ml
Method : Fully Automated Immuno Turbidometry
CREATININE - URINE PHOTOMETRY 134.14 mg/dL
Bio. Ref. Interval. :
Male: 39 - 259 mg/dl
Female: 28 - 217 mg/dl
Method : Creatinine Jaffe Method, Rate-Blanked and Compensated
URI. ALBUMIN/CREATININE RATIO (UA/C) CALCULATED 13.6 µg/mg of Creatinine
Bio. Ref. Interval. :
Adults : Less than 30 µg/mg of Creatinine
Method : Derived from Albumin and Creatinine values
Please correlate with clinical conditions.

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 13:08

Report Released on (RRT) : 09 Jan 2024 14:45
Sample Type : URINE
Labcode : 0901075282/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : AS322623
Page : 1 of 14
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY (5600162028),SWATHI,M1, 2ND MAIN, URBAN
: DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : HbA1c,HEMOGRAM Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME TECHNOLOGY VALUE UNITS

HbA1c - (HPLC)
H.P.L.C 6.5 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 140 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:04

Report Released on (RRT) : 09 Jan 2024 12:58
Sample Type : EDTA
Labcode : 0901070551/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : AS713963
Page : 2 of 14
 PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY : DR SWATHIK,MBBS (5600162028),SWATHI,M1, 2ND MAIN, URBAN
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : HbA1c,HEMOGRAM
Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME VALUE UNITS Bio. Ref. Interval.

TOTAL LEUCOCYTES COUNT (WBC) 6.83 X 10³ / µL 4.0 - 10.0
NEUTROPHILS 63.2 % 40-80
LYMPHOCYTE 28.8 % 20-40
MONOCYTES 3.1 % 2-10
EOSINOPHILS 3.8 % 1-6
BASOPHILS 1 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.1 % 0.0-0.4
NEUTROPHILS - ABSOLUTE COUNT 4.32 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 1.97 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.21 X 10³ / µL 0.2 - 1.0
BASOPHILS - ABSOLUTE COUNT 0.07 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT 0.26 X 10³ / µL 0.02 - 0.5
IMMATURE GRANULOCYTES(IG) 0.01 X 10³ / µL 0.0-0.3
TOTAL RBC 4.39 X 10^6/µL 3.8-4.8
NUCLEATED RED BLOOD CELLS 0.01 X 10³ / µL 0.0-0.5
NUCLEATED RED BLOOD CELLS % 0.01 % 0.0-5.0
HEMOGLOBIN 12.1 g/dL 12.0-15.0
HEMATOCRIT(PCV) 37.8 % 36.0-46.0
MEAN CORPUSCULAR VOLUME(MCV) 86.1 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 27.6 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) 32 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 43.9 fL 39.0-46.0
RED CELL DISTRIBUTION WIDTH (RDW-CV) 14.2 % 11.6-14.0
PLATELET DISTRIBUTION WIDTH(PDW) 11.7 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) 10.4 fL 6.5-12
PLATELET COUNT 340 X 10³ / µL 150-410
PLATELET TO LARGE CELL RATIO(PLCR) 28.1 % 19.7-42.4
PLATELETCRIT(PCT) 0.35 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

Please Correlate with clinical conditions.

Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Method
(using a semiconductor laser), and SLS- hemoglobin method)

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:04
Report Released on (RRT) : 09 Jan 2024 12:58
Sample Type : EDTA
Labcode : 0901070551/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : AS713963 Page : 3 of 14
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY : DR SWATHIK,MBBS (5600162028),SWATHI,M1, 2ND MAIN, URBAN
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : BLOOD SUGAR (F)
Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME TECHNOLOGY VALUE UNITS

FASTING BLOOD SUGAR(GLUCOSE) PHOTOMETRY 107.5 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Fasting Plasma Glucose (FPG)

Normal 70 to 100 mg/dl

Prediabetes 100 mg/dl to 125 mg/dl

Diabetes 126 mg/dl or higher

Note :
The assay could be affected mildly and may result in anomalous values if serum samples have heterophilic antibodies, hemolyzed ,
icteric or lipemic. The concentration of Glucose in a given specimen may vary due to differences in assay methods, calibration and
reagent specificity. For diagnostic purposes results should always be assessed in conjunction with patients medical history, clinical
findings and other findings.
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06
Report Released on (RRT) : 09 Jan 2024 13:17
Sample Type : FLUORIDE
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0901070757/AY022
Barcode : AU157508 Page : 4 of 14
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY : DR SWATHIK,MBBS (5600162028),SWATHI,M1, 2ND MAIN, URBAN
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : BLOOD SUGAR (PP)
Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME TECHNOLOGY VALUE UNITS

POSTPRANDIAL BLOOD SUGAR(GLUCOSE) PHOTOMETRY 139.8 mg/dL

Bio. Ref. Interval. :-

As per ADA Guideline: Random/Post-Prandial Plasma

Glucose (RPG/PPPG)

Normal 70 to 140 mg/dl

Impaired Glucose 140 - 199 mg/dl

Tolerance

Diabetes Greater than or Equal to 200

mg/dl
Please correlate with clinical conditions.
Method:- GOD-PAP METHOD

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:07
Report Released on (RRT) : 09 Jan 2024 13:17
Sample Type : FLUORIDE
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0901070922/AY022
Barcode : BL508209 Page : 5 of 14
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY (5600162028),SWATHI,M1, 2ND MAIN, URBAN
: DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : JAANCH - DIABETIC PROFILE BASIC Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME TECHNOLOGY VALUE UNITS

BLOOD KETONE (D3HB) PHOTOMETRY 0.21 mg/dL

Bio. Ref. Interval. :
0.21-2.81 mg/dL

Clinical Significance:
Three types of ketones can be produced in body D-3- Hydroxybutyrate, Acetoacetate and Acetone. D-3- Hydroxybutyrate accounts
for approximately 75% of the ketone bodies. During periods of ketosis, D-3- Hydroxybutyrate increases more than the other two. It
has been shown to be a better index of ketoacidosis. In diabetics, D-3- Hydroxybutyrate is needed for the assessment of the
severity of diabetic coma and to calculate insulin requirements.

Speficcation:
Precision: Intra assay (%CV): 4.53, Inter assay (%CV): 2.9, Sensitivity: 10.41 mg/dL.

Kit validation references:

Mcmurray, C.H., Blanchflower, W.J., Rice, D.A., ClinChem., 1984;30:No.3.
Method : ENZYMATIC (KINETIC)
FRUCTOSAMINE PHOTOMETRY 265.3 µmol/L
Bio. Ref. Interval. :

Normal < 286 µmol/L

Clinical Significance:

Fructosamine assay is useful in monitoring the degree of glycemia over short-to-intermediate time frames (1-3 weeks) concentration
greater than the established normal range is an indication of prolonged hyperglycemia of 1-3 weeks or longer. The higher
fructosamine value, poorer is the degree of glycemia control.

Specifications:

Precision %CV : Intra assay %CV- 3.2% , Inter assay %CV-4.0%, Sensitivity:- 290 umol/L

Kit Validation Reference:

Howey JEA, Browning MCK, Fraser CG. Assay of serum fructosamine that minimizes standardization and matrix problems: Use to
assess components of biological va-riation. Clin Chem 1987; 33: 269- 272.
Method : NITROBLUE TETRAZOLIUM ASSAY (NBT)
Please correlate with clinical conditions.

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06

Report Released on (RRT) : 09 Jan 2024 15:05
Sample Type : SERUM
Labcode : 0901070768/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : BL887211
Page : 6 of 14
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY (5600162028),SWATHI,M1, 2ND MAIN, URBAN
: DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : JAANCH - DIABETIC PROFILE BASIC Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 61.3 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170
Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 390.1 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 15.71 %
Bio. Ref. Interval. :
13 - 45
Method : DERIVED FROM IRON AND TIBC VALUES
UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 328.8 µg/dL
Bio. Ref. Interval. :
162 - 368
Method : SPECTROPHOTOMETRIC ASSAY
Please correlate with clinical conditions.

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06

Report Released on (RRT) : 09 Jan 2024 15:05
Sample Type : SERUM
Labcode : 0901070768/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : BL887211
Page : 7 of 14
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY (5600162028),SWATHI,M1, 2ND MAIN, URBAN
: DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu Chetty
TEST ASKED : JAANCH - DIABETIC PROFILE BASIC Palya, Krishnarajapura, Bengaluru, Karnataka 560036,
India,560016

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL CHOLESTEROL PHOTOMETRY 234 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 39 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 178 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 149 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 6 Ratio 3-5
TRIG / HDL RATIO CALCULATED 3.78 Ratio < 3.12
LDL / HDL RATIO CALCULATED 4.5 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.22 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 195 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 29.76 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - CHOLESTEROL OXIDASE, ESTERASE, PEROXIDASE
HCHO - DIRECT ENZYMATIC COLORIMETRIC
LDL - DIRECT MEASURE
TRIG - ENZYMATIC, END POINT
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
TRI/H - DERIVED FROM TRIG AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
HD/LD - DERIVED FROM HDL AND LDL VALUES.
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06
Report Released on (RRT) : 09 Jan 2024 15:05
Sample Type : SERUM
Labcode : 0901070768/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : BL887211 Page : 8 of 14

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY (5600162028),SWATHI,M1, 2ND MAIN, URBAN
: DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu Chetty
TEST ASKED : JAANCH - DIABETIC PROFILE BASIC Palya, Krishnarajapura, Bengaluru, Karnataka 560036,
India,560016

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

ALKALINE PHOSPHATASE PHOTOMETRY 85.11 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.5 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.11 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.34 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 38.5 U/L < 38
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 24.6 U/L < 31
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 19.6 U/L < 34
SGOT / SGPT RATIO CALCULATED 1.25 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.96 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.1 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 3.86 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.06 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
OT/PT - DERIVED FROM SGOT AND SGPT VALUES.
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06
Report Released on (RRT) : 09 Jan 2024 15:05
Sample Type : SERUM
Labcode : 0901070768/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : BL887211 Page : 9 of 14

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY (5600162028),SWATHI,M1, 2ND MAIN, URBAN
: DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : JAANCH - DIABETIC PROFILE BASIC Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME TECHNOLOGY VALUE UNITS

SODIUM I.S.E 138.08 mmol/L

Bio. Ref. Interval. :
ADULTS: 136-145 MMOL/L
Method : ION SELECTIVE ELECTRODE
CHLORIDE I.S.E 101.86 mmol/L
Bio. Ref. Interval. :
ADULTS: 98-107 MMOL/L

Clinical Significance :
An increased level of blood chloride (called hyperchloremia) usually indicates dehydration, but can also occur with other problems that
cause high blood sodium, such as Cushing syndrome or kidney disease. Hyperchloremia also occurs when too much base is lost from
the body (producing metabolic acidosis) or when a person hyperventilates (causing respiratory alkalosis). A decreased level of blood
chloride (called hypochloremia) occurs with any disorder that causes low blood sodium. Hypochloremia also occurs with congestive
heart failure, prolonged vomiting or gastric suction, Addison disease, emphysema or other chronic lung diseases (causing respiratory
acidosis), and with loss of acid from the body (called metabolic alkalosis).
Method : ION SELECTIVE ELECTRODE
Please correlate with clinical conditions.

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06

Report Released on (RRT) : 09 Jan 2024 15:05
Sample Type : SERUM
Labcode : 0901070768/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : BL887211
Page : 10 of 14
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY (5600162028),SWATHI,M1, 2ND MAIN, URBAN
: DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu Chetty
TEST ASKED : JAANCH - DIABETIC PROFILE BASIC Palya, Krishnarajapura, Bengaluru, Karnataka 560036,
India,560016

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

BLOOD UREA NITROGEN (BUN) PHOTOMETRY 13.6 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 1.05 mg/dL 0.55-1.02
BUN / SR.CREATININE RATIO CALCULATED 12.95 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 29.1 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 27.72 Ratio < 52
CALCIUM PHOTOMETRY 9.4 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 7.45 mg/dL 3.2 - 6.1
Please correlate with clinical conditions.

Method :
BUN - KINETIC UV ASSAY.
SCRE - CREATININE ENZYMATIC METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
UREAC - DERIVED FROM BUN VALUE.
UR/CR - DERIVED FROM UREA AND SR.CREATININE VALUES.
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06
Report Released on (RRT) : 09 Jan 2024 15:05
Sample Type : SERUM
Labcode : 0901070768/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : BL887211 Page : 11 of 14

 PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

(5600162028),SWATHI,M1, 2ND MAIN, URBAN
REF. BY : DR SWATHIK,MBBS
CLUSTERS LAYOUT, Brindavan Layout, Thambu Chetty
TEST ASKED : JAANCH - DIABETIC PROFILE BASIC Palya, Krishnarajapura, Bengaluru, Karnataka 560036,
India,560016

TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.

TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 116 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 9.41 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 4.78 µIU/mL 0.54-5.30

Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06
Report Released on (RRT) : 09 Jan 2024 15:05
Sample Type : SERUM
Labcode : 0901070768/AY022 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : BL887211 Page : 12 of 14
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : MRS G UMA (57Y/F) SAMPLE COLLECTED AT :

REF. BY : DR SWATHIK,MBBS (5600162028),SWATHI,M1, 2ND MAIN, URBAN
CLUSTERS LAYOUT, Brindavan Layout, Thambu
TEST ASKED : JAANCH - DIABETIC PROFILE BASIC
Chetty Palya, Krishnarajapura, Bengaluru,
Karnataka 560036, India,560016

TEST NAME TECHNOLOGY VALUE UNITS

EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 59 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

~~ End of report ~~

Sample Collected on (SCT) : 09 Jan 2024 10:23

Sample Received on (SRT) : 09 Jan 2024 12:06
Report Released on (RRT) : 09 Jan 2024 15:05
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0901070768/AY022
Barcode : BL887211 Page : 13 of 14
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333

*As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 14 of 14